Stockreport

Immuneering to be Added to the Nasdaq Biotechnology Index (NBI)

Immuneering Corporation - Class A  (IMRX) 
PDF NEW YORK, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a late-stage clinical oncology company focused on keeping cancer patients alive and [Read more]